Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

To the Editor- Rhythmologic challenges following heart transplantation.

Sindermann JR, Welp HA, Pott C, Mönnig G.

HeartRhythm Case Rep. 2017 Oct 17;3(12):608. doi: 10.1016/j.hrcr.2017.09.008. eCollection 2017 Dec. No abstract available.

2.

Occurrence of primarily noninducible atrioventricular nodal reentry tachycardia after radiofrequency delivery in the slow pathway region during empirical slow pathway modulation.

Wegner FK, Bögeholz N, Leitz P, Frommeyer G, Dechering DG, Kochhäuser S, Lange PS, Köbe J, Wasmer K, Mönnig G, Eckardt L, Pott C.

Clin Cardiol. 2017 Nov;40(11):1112-1115. doi: 10.1002/clc.22797. Epub 2017 Nov 22.

3.

The Effects of SEA0400 on Ca2+ Transient Amplitude and Proarrhythmia Depend on the Na+/Ca2+ Exchanger Expression Level in Murine Models.

Bögeholz N, Schulte JS, Kaese S, Bauer BK, Pauls P, Dechering DG, Frommeyer G, Goldhaber JI, Kirchhefer U, Eckardt L, Pott C, Müller FU.

Front Pharmacol. 2017 Sep 21;8:649. doi: 10.3389/fphar.2017.00649. eCollection 2017.

4.

Patients' and procedural characteristics of AV-block during slow pathway modulation for AVNRT-single center 10year experience.

Wasmer K, Dechering DG, Köbe J, Leitz P, Frommeyer G, Lange PS, Kochhäuser S, Reinke F, Pott C, Mönnig G, Breithardt G, Eckardt L.

Int J Cardiol. 2017 Oct 1;244:158-162. doi: 10.1016/j.ijcard.2017.06.043. Epub 2017 Jun 15.

PMID:
28663043
5.

Restoring effective sleep tranquility (REST): A feasibility and pilot study.

Eakman AM, Schmid AA, Henry KL, Rolle NR, Schelly C, Pott CE, Burns JE.

Br J Occup Ther. 2017 Jun;80(6):350-360. doi: 10.1177/0308022617691538. Epub 2017 Apr 5.

6.

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.

Xochelli A, Baliakas P, Kavakiotis I, Agathangelidis A, Sutton LA, Minga E, Ntoufa S, Tausch E, Yan XJ, Shanafelt T, Plevova K, Boudjogra M, Rossi D, Davis Z, Navarro A, Sandberg Y, Vojdeman FJ, Scarfo L, Stavroyianni N, Sudarikov A, Veronese S, Tzenou T, Karan-Djurasevic T, Catherwood M, Kienle D, Chatzouli M, Facco M, Bahlo J, Pott C, Pedersen LB, Mansouri L, Smedby KE, Chu CC, Giudicelli V, Lefranc MP, Panagiotidis P, Juliusson G, Anagnostopoulos A, Vlahavas I, Antic D, Trentin L, Montillo M, Niemann C, Döhner H, Langerak AW, Pospisilova S, Hallek M, Campo E, Chiorazzi N, Maglaveras N, Oscier D, Gaidano G, Jelinek DF, Stilgenbauer S, Chouvarda I, Darzentas N, Belessi C, Davi F, Hadzidimitriou A, Rosenquist R, Ghia P, Stamatopoulos K.

Clin Cancer Res. 2017 Sep 1;23(17):5292-5301. doi: 10.1158/1078-0432.CCR-16-3100. Epub 2017 May 23.

PMID:
28536306
7.

Increased sodium/calcium exchanger activity enhances beta-adrenergic-mediated increase in heart rate: Whole-heart study in a homozygous sodium/calcium exchanger overexpressor mouse model.

Kaese S, Bögeholz N, Pauls P, Dechering D, Olligs J, Kölker K, Badawi S, Frommeyer G, Pott C, Eckardt L.

Heart Rhythm. 2017 Aug;14(8):1247-1253. doi: 10.1016/j.hrthm.2017.05.001. Epub 2017 May 8.

PMID:
28495655
8.

Circumferential pulmonary vein isolation with second-generation multipolar catheter in patients with paroxysmal or persistent atrial fibrillation: Procedural and one-year follow-up results.

Spitzer SG, Leitz P, Langbein A, Karolyi L, Scharfe F, Weinmann T, Rämmler C, Pott C, Mönnig G, Eckardt L.

Int J Cardiol. 2017 Aug 15;241:212-217. doi: 10.1016/j.ijcard.2017.04.035. Epub 2017 Apr 12.

PMID:
28427852
9.

High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges.

Langerak AW, Brüggemann M, Davi F, Darzentas N, van Dongen JJM, Gonzalez D, Cazzaniga G, Giudicelli V, Lefranc MP, Giraud M, Macintyre EA, Hummel M, Pott C, Groenen PJTA, Stamatopoulos K; EuroClonality-NGS Consortium.

J Immunol. 2017 May 15;198(10):3765-3774. doi: 10.4049/jimmunol.1602050. Epub 2017 Apr 17.

PMID:
28416603
10.

Eobowenia gen. nov. from the Early Cretaceous of Patagonia: indication for an early divergence of Bowenia?

Coiro M, Pott C.

BMC Evol Biol. 2017 Apr 7;17(1):97. doi: 10.1186/s12862-017-0943-x.

11.

ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.

Ladetto M, Buske C, Hutchings M, Dreyling M, Gaidano G, Le Gouill S, Luminari S, Pott C, Zamò A, Zucca E; & the ESMO Lymphoma Consensus Conference Panel Members.

Ann Oncol. 2018 Feb 1;29(2):525. doi: 10.1093/annonc/mdx061. No abstract available.

PMID:
28368466
12.

MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma.

Akyüz N, Albert-Konetzny N, Pott C, Callet-Bauchu E, Bokemeyer C, Murga Penas EM, Dierlamm J.

Leuk Lymphoma. 2017 Oct;58(10):2480-2484. doi: 10.1080/10428194.2017.1296144. Epub 2017 Mar 2. No abstract available.

PMID:
28278699
13.

Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?

Frommeyer G, Sterneberg M, Dechering DG, Ellermann C, Bögeholz N, Kochhäuser S, Pott C, Fehr M, Eckardt L.

Int J Cardiol. 2017 Jun 1;236:237-243. doi: 10.1016/j.ijcard.2017.02.055. Epub 2017 Feb 27.

PMID:
28262346
14.

Routine 18F-FDG PET/CT does not detect inflammation in the left atrium in patients with atrial fibrillation.

Lange PS, Avramovic N, Frommeyer G, Wasmer K, Pott C, Eckardt L, Wenning C.

Int J Cardiovasc Imaging. 2017 Aug;33(8):1271-1276. doi: 10.1007/s10554-017-1094-2. Epub 2017 Feb 22.

15.

ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data.

Bystry V, Reigl T, Krejci A, Demko M, Hanakova B, Grioni A, Knecht H, Schlitt M, Dreger P, Sellner L, Herrmann D, Pingeon M, Boudjoghra M, Rijntjes J, Pott C, Langerak AW, Groenen PJ, Davi F, Brüggemann M, Darzentas N; also on Behalf of EuroClonality-NGS.

Bioinformatics. 2017 Feb 1;33(3):435-437. doi: 10.1093/bioinformatics/btw634.

PMID:
28172348
16.

Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.

Frommeyer G, Sterneberg M, Dechering DG, Kaese S, Bögeholz N, Pott C, Fehr M, Bogossian H, Milberg P, Eckardt L.

Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12244.

PMID:
28039911
17.

Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment.

Hoster E, Pott C.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):437-445. Review.

PMID:
27913513
18.

Experimental evidence for a severe proarrhythmic potential of levosimendan.

Frommeyer G, Kohnke A, Ellermann C, Dechering DG, Kochhäuser S, Pott C, Fehr M, Eckardt L.

Int J Cardiol. 2017 Feb 1;228:583-587. doi: 10.1016/j.ijcard.2016.11.251. Epub 2016 Nov 14.

PMID:
27875737
19.

Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencing.

Wren D, Walker BA, Brüggemann M, Catherwood MA, Pott C, Stamatopoulos K, Langerak AW, Gonzalez D; EuroClonality-NGS consortium.

Haematologica. 2017 Feb;102(2):e57-e60. doi: 10.3324/haematol.2016.155424. Epub 2016 Oct 20. No abstract available.

20.

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.

Queirós AC, Beekman R, Vilarrasa-Blasi R, Duran-Ferrer M, Clot G, Merkel A, Raineri E, Russiñol N, Castellano G, Beà S, Navarro A, Kulis M, Verdaguer-Dot N, Jares P, Enjuanes A, Calasanz MJ, Bergmann A, Vater I, Salaverría I, van de Werken HJG, Wilson WH, Datta A, Flicek P, Royo R, Martens J, Giné E, Lopez-Guillermo A, Stunnenberg HG, Klapper W, Pott C, Heath S, Gut IG, Siebert R, Campo E, Martín-Subero JI.

Cancer Cell. 2016 Nov 14;30(5):806-821. doi: 10.1016/j.ccell.2016.09.014.

21.

Triggered activity in atrial myocytes is influenced by Na+/Ca2+ exchanger activity in genetically altered mice.

Bögeholz N, Pauls P, Kaese S, Schulte JS, Lemoine MD, Dechering DG, Frommeyer G, Goldhaber JI, Seidl MD, Kirchhefer U, Eckardt L, Müller FU, Pott C.

J Mol Cell Cardiol. 2016 Dec;101:106-115. doi: 10.1016/j.yjmcc.2016.11.004. Epub 2016 Nov 9.

22.

Antiarrhythmic effect of vernakalant in an experimental model of Long-QT-syndrome.

Frommeyer G, Clauss C, Ellermann C, Bogossian H, Dechering DG, Kochhäuser S, Reinke F, Pott C, Eckardt L.

Europace. 2017 May 1;19(5):866-873. doi: 10.1093/europace/euw182.

PMID:
27702859
23.

ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.

Ladetto M, Buske C, Hutchings M, Dreyling M, Gaidano G, Le Gouill S, Luminari S, Pott C, Zamò A, Zucca E; ESMO Lymphoma Consensus Conference Panel Members.

Ann Oncol. 2016 Dec;27(12):2149-2160. doi: 10.1093/annonc/mdw419. Epub 2016 Oct 4.

24.

Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.

Frommeyer G, von der Ahe H, Brücher B, Dechering DG, Lange PS, Reinke F, Wasmer K, Köbe J, Pott C, Mönnig G, Eckardt L.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Oct;389(10):1073-80. doi: 10.1007/s00210-016-1274-y. Epub 2016 Jul 12.

PMID:
27405774
25.

Influence of Clinical Parameters and Anticoagulation on Intraprocedural Cerebral Microembolic Signals during Pulmonary Vein Isolation.

Larbig R, Dittrich R, Kochhaeuser S, Leitz P, Guener F, Korsukewitz C, Dechering D, Pott C, Wasmer K, Schmitges J, Kerckhoff M, Eckardt L, Moennig G.

PLoS One. 2016 Jun 21;11(6):e0157886. doi: 10.1371/journal.pone.0157886. eCollection 2016.

26.

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.

Hermine O, Hoster E, Walewski J, Bosly A, Stilgenbauer S, Thieblemont C, Szymczyk M, Bouabdallah R, Kneba M, Hallek M, Salles G, Feugier P, Ribrag V, Birkmann J, Forstpointner R, Haioun C, Hänel M, Casasnovas RO, Finke J, Peter N, Bouabdallah K, Sebban C, Fischer T, Dührsen U, Metzner B, Maschmeyer G, Kanz L, Schmidt C, Delarue R, Brousse N, Klapper W, Macintyre E, Delfau-Larue MH, Pott C, Hiddemann W, Unterhalt M, Dreyling M; European Mantle Cell Lymphoma Network.

Lancet. 2016 Aug 6;388(10044):565-75. doi: 10.1016/S0140-6736(16)00739-X. Epub 2016 Jun 14.

PMID:
27313086
27.

Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.

Frommeyer G, Ellermann C, Dechering DG, Kochhäuser S, Bögeholz N, Güner F, Leitz P, Pott C, Eckardt L.

J Cardiovasc Electrophysiol. 2016 Oct;27(10):1214-1219. doi: 10.1111/jce.13029. Epub 2016 Jul 13.

PMID:
27283775
28.

Pulmonary vein reconnection and arrhythmia progression after antral linear catheter ablation of paroxysmal and persistent atrial fibrillation.

Wasmer K, Dechering DG, Köbe J, Mönnig G, Pott C, Frommeyer G, Lange PS, Kochhäuser S, Eckardt L.

Clin Res Cardiol. 2016 Sep;105(9):738-43. doi: 10.1007/s00392-016-0980-2. Epub 2016 Apr 5.

PMID:
27048420
29.

Slow pathway modification in patients presenting with only two consecutive AV nodal echo beats.

Wegner FK, Silvano M, Bögeholz N, Leitz PR, Frommeyer G, Dechering DG, Zellerhoff S, Kochhäuser S, Lange PS, Köbe J, Wasmer K, Mönnig G, Eckardt L, Pott C.

J Cardiol. 2017 Feb;69(2):471-475. doi: 10.1016/j.jjcc.2016.02.011. Epub 2016 Mar 25.

30.

Incidence and management of inadvertent puncture and sheath placement in the aorta during attempted transseptal puncture.

Wasmer K, Zellerhoff S, Köbe J, Mönnig G, Pott C, Dechering DG, Lange PS, Frommeyer G, Eckardt L.

Europace. 2017 Mar 1;19(3):447-457. doi: 10.1093/europace/euw037.

PMID:
27001035
31.

Lower rate of left atrial tachycardia after pulmonary vein isolation with PVAC versus irrigated-tip circumferential antral ablation.

Wasmer K, Krüsemann D, Leitz P, Güner F, Pott C, Zellerhoff S, Dechering D, Köbe J, Lange PS, Eckardt L, Mönnig G.

Heart Rhythm. 2016 Aug;13(8):1596-601. doi: 10.1016/j.hrthm.2016.02.017. Epub 2016 Feb 24.

PMID:
26921761
32.

Data on procedural handling and complications of pulmonary vein isolation using the pulmonary vein ablation catheter GOLD®.

Leitz P, Güner F, Wasmer K, Foraita P, Pott C, Dechering DG, Zellerhoff S, Kochhäuser S, Lange PS, Eckardt L, Mönnig G.

Europace. 2016 May;18(5):696-701. doi: 10.1093/europace/euv355. Epub 2015 Dec 23.

PMID:
26705559
33.

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

Ljungström V, Cortese D, Young E, Pandzic T, Mansouri L, Plevova K, Ntoufa S, Baliakas P, Clifford R, Sutton LA, Blakemore SJ, Stavroyianni N, Agathangelidis A, Rossi D, Höglund M, Kotaskova J, Juliusson G, Belessi C, Chiorazzi N, Panagiotidis P, Langerak AW, Smedby KE, Oscier D, Gaidano G, Schuh A, Davi F, Pott C, Strefford JC, Trentin L, Pospisilova S, Ghia P, Stamatopoulos K, Sjöblom T, Rosenquist R.

Blood. 2016 Feb 25;127(8):1007-16. doi: 10.1182/blood-2015-10-674572. Epub 2015 Dec 16.

34.

Esophageal and Mediastinal Lesions Following Multielectrode Duty-Cycled Radiofrequency Pulmonary Vein Isolation: Simple Equals Safe?

Zellerhoff S, Lenze F, Ullerich H, Bittner A, Wasmer K, Köbe J, Pott C, Eckardt L, Mönnig G.

Pacing Clin Electrophysiol. 2016 Apr;39(4):316-20. doi: 10.1111/pace.12797. Epub 2016 Jan 21.

PMID:
26644279
35.

Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.

Hoster E, Geisler CH, Doorduijn J, van der Holt B, Walewski J, Bloehdorn J, Ribrag V, Salles G, Hallek M, Pott C, Szymczyk M, Kolstad A, Laurell A, Räty R, Jerkeman M, Van't Veer M, Kluin-Nelemans JC, Klapper W, Unterhalt M, Dreyling M, Hermine O.

Leukemia. 2016 Jun;30(6):1428-30. doi: 10.1038/leu.2015.322. Epub 2015 Nov 24. No abstract available.

PMID:
26598017
36.

Suppression of Early and Late Afterdepolarizations by Heterozygous Knockout of the Na+/Ca2+ Exchanger in a Murine Model.

Bögeholz N, Pauls P, Bauer BK, Schulte JS, Dechering DG, Frommeyer G, Kirchhefer U, Goldhaber JI, Müller FU, Eckardt L, Pott C.

Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1210-8. doi: 10.1161/CIRCEP.115.002927. Epub 2015 Sep 3.

37.

The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL.

Kotrova M, Muzikova K, Mejstrikova E, Novakova M, Bakardjieva-Mihaylova V, Fiser K, Stuchly J, Giraud M, Salson M, Pott C, Brüggemann M, Füllgrabe M, Stary J, Trka J, Fronkova E.

Blood. 2015 Aug 20;126(8):1045-7. doi: 10.1182/blood-2015-07-655159. No abstract available.

38.

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, Pott C, Kopp N, Murakami M, Horn H, Leich E, Moccia AA, Mottok A, Sunkavalli A, Van Hummelen P, Ducar M, Ennishi D, Shulha HP, Hother C, Connors JM, Sehn LH, Dreyling M, Neuberg D, Möller P, Feller AC, Hansmann ML, Stein H, Rosenwald A, Ott G, Klapper W, Unterhalt M, Hiddemann W, Gascoyne RD, Weinstock DM, Weigert O.

Lancet Oncol. 2015 Sep;16(9):1111-1122. doi: 10.1016/S1470-2045(15)00169-2. Epub 2015 Aug 6.

PMID:
26256760
39.

Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.

Aukema SM, Theil L, Rohde M, Bauer B, Bradtke J, Burkhardt B, Bonn BR, Claviez A, Gattenlöhner S, Makarova O, Nagel I, Oschlies I, Pott C, Szczepanowski M, Traulsen A, Kluin PM, Klapper W, Siebert R, Murga Penas EM.

Br J Haematol. 2015 Sep;170(6):814-25. doi: 10.1111/bjh.13501. Epub 2015 Jun 24.

PMID:
26104998
40.

High-Throughput, Amplicon-Based Sequencing of the CREBBP Gene as a Tool to Develop a Universal Platform-Independent Assay.

Fuellgrabe MW, Herrmann D, Knecht H, Kuenzel S, Kneba M, Pott C, Brüggemann M.

PLoS One. 2015 Jun 9;10(6):e0129195. doi: 10.1371/journal.pone.0129195. eCollection 2015.

41.

Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.

Wehkamp U, Pott C, Unterhalt M, Koch K, Weichenthal M, Klapper W, Oschlies I.

Am J Surg Pathol. 2015 Aug;39(8):1093-101. doi: 10.1097/PAS.0000000000000445.

PMID:
26034867
42.

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.

Delfau-Larue MH, Klapper W, Berger F, Jardin F, Briere J, Salles G, Casasnovas O, Feugier P, Haioun C, Ribrag V, Thieblemont C, Unterhalt M, Dreyling M, Macintyre E, Pott C, Hermine O, Hoster E; European Mantle Cell Lymphoma Network.

Blood. 2015 Jul 30;126(5):604-11. doi: 10.1182/blood-2015-02-628792. Epub 2015 May 28.

43.

Outcome predictors of empirical slow pathway modulation: clinical and procedural characteristics and long-term follow-up.

Pott C, Wegner FK, Bögeholz N, Frommeyer G, Dechering DG, Zellerhoff S, Kochhäuser S, Milberg P, Köbe J, Wasmer K, Breithardt G, Mönnig G, Eckardt L.

Clin Res Cardiol. 2015 Nov;104(11):946-54. doi: 10.1007/s00392-015-0862-z. Epub 2015 May 21.

PMID:
25994855
44.

Dual atrioventricular nodal non-re-entrant tachycardia.

Peiker C, Pott C, Eckardt L, Kelm M, Shin DI, Willems S, Meyer C.

Europace. 2016 Mar;18(3):332-9. doi: 10.1093/europace/euv056. Epub 2015 Apr 16. Review.

PMID:
25888570
45.

Safety profile of multielectrode-phased radiofrequency pulmonary vein ablation catheter and irrigated radiofrequency catheter.

Wasmer K, Foraita P, Leitz P, Güner F, Pott C, Lange PS, Eckardt L, Mönnig G.

Europace. 2016 Jan;18(1):78-84. doi: 10.1093/europace/euv046. Epub 2015 Apr 16.

PMID:
25883082
46.

Molecular evidence for antigen drive in the natural history of mantle cell lymphoma.

Xochelli A, Sutton LA, Agathangelidis A, Stalika E, Karypidou M, Marantidou F, Lopez AN, Papadopoulos G, Supikova J, Groenen P, Boudjogra M, Sundstrom C, Ponzoni M, Francova HS, Anagnostopoulos A, Pospisilova S, Papadaki T, Tzovaras D, Ghia P, Pott C, Davi F, Campo E, Rosenquist R, Hadzidimitriou A, Belessi C, Stamatopoulos K.

Am J Pathol. 2015 Jun;185(6):1740-8. doi: 10.1016/j.ajpath.2015.02.006. Epub 2015 Apr 2.

PMID:
25843681
47.

Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.

Chumduri C, Gillissen B, Richter A, Richter A, Milojkovic A, Overkamp T, Müller A, Pott C, Daniel PT.

J Mol Med (Berl). 2015 May;93(5):559-72. doi: 10.1007/s00109-014-1242-2. Epub 2014 Dec 30.

PMID:
25548804
48.

Genomic and epigenomic co-evolution in follicular lymphomas.

Loeffler M, Kreuz M, Haake A, Hasenclever D, Trautmann H, Arnold C, Winter K, Koch K, Klapper W, Scholtysik R, Rosolowski M, Hoffmann S, Ammerpohl O, Szczepanowski M, Herrmann D, Küppers R, Pott C, Siebert R; HaematoSys-Project.

Leukemia. 2015 Feb;29(2):456-63. doi: 10.1038/leu.2014.209. Epub 2014 Jul 16.

PMID:
25027518
49.

Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.

Dreyling M, Amador V, Callanan M, Jerkeman M, Le Gouill S, Pott C, Rule S, Zaja F; European Mantle Cell Lymphoma Network.

Leuk Lymphoma. 2015 Apr;56(4):866-76. doi: 10.3109/10428194.2014.940584. Epub 2014 Aug 20.

PMID:
25015778
50.

Response to the letter regarding article "A patient series of dual atrioventricular nodal nonreentrant tachycardia (DAVNNT)--an often overlooked diagnosis?".

Pott C, Wegner FK, Wasmer K, Mönnig G, Eckardt L.

Int J Cardiol. 2014 Aug 1;175(2):366-7. doi: 10.1016/j.ijcard.2014.04.146. Epub 2014 Apr 28. No abstract available.

PMID:
24882695

Supplemental Content

Support Center